LIXTE Biotechnology Holdings, Inc.

LIXT

🇺🇸

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Read More...

ETH Holdings

300

ETH Price

$2,852

-$79.67 (-2.72%)

Stock Price

$3.96

Net Asset Value

$856K

Digital Asset Treasury

Total Holdings

300

% of Supply

0.0002%

Avg. Cost

Unrealized P/L

Total Cost

Current Progress

Acquisition Target

Circulating Supply

120,695,059.41

% of Circulating Supply

Max Supply

Stock

Stock Price

$3.96

Market Cap

Enterprise Value

Basic Shares

Diluted Shares

Market Performance

ETH NAV

$855,600

mNAV

Fully Diluted mNAV

Forward mNAV

NAV per Basic Share

N/A

NAV per Diluted Share

N/A

ETH per 1000 Shares

Transactions

Total Transactions

Investment Period

100 Days

Purchases

Sales

Avg. Transaction Size

300

Avg. Days Between Transactions

Loading chart...

ETH Purchase Records

1 transactions found

WhaleAgent.io

Date	Holdings	Acquired	Avg Cost	Cost Basis	Basic Shares	Diluted Shares
Sep 10, 2025	300	300	$0	$0	-	-

Disclaimer

The information provided is for informational purposes only and does not constitute investment advice. Transaction data is compiled from company filings and press releases and may be incomplete. Prices shown are in real-time but may vary across exchanges. Estimated values may differ due to currency conversion rates. Users are strongly encouraged to independently verify all information before making any investment decisions. If you notice any inaccuracies, please feel free to contact us.

Found an issue?